Food and Drug Administration
and the
September 14, 2004
Slides
Summary Comments on Antidepressants and Suicidality in Pediatric Patients & Questions/Topics for Comment, Dr. Thomas Laughren, MD, FDA (HTM) (PPT)
Recent Observational Studies of Antidepressants (ADs) and Suicidal Behavior, Dr. Diane Wysowski, PhD, FDA (HTM) (PPT)